Security readout for executives and security teams
Plain-English summary
CVE-2023-6515 is an authorization flaw in Mia Technology’s MİA-MED before version 1.0.7. A logged-in user could potentially manipulate a user-controlled identifier to access or change data they should not control. Because healthcare systems can contain sensitive patient and operational data, this should be treated as high business risk where MİA-MED is deployed.
Executive priority
High priority for healthcare or clinical environments using MİA-MED. The issue could affect sensitive data and system integrity, but the provided sources do not confirm active exploitation. Address during the next urgent maintenance window after confirming product presence and version.
Technical view
The CVE describes CWE-639, Authorization Bypass Through User-Controlled Key, commonly known as IDOR. It affects MİA-MED before 1.0.7 and has CVSS 3.1 score 8.8, with network access, low complexity, low privileges, no user interaction, and high confidentiality, integrity, and availability impact.
Likely exposure
Exposure is likely limited to organizations running Mia Technology MİA-MED versions before 1.0.7. The CVE does not state whether vulnerable instances are typically internet-facing. Prioritize systems accessible to regular users, remote users, partner networks, or the public internet.
Exploitation context
The source bundle does not show CISA KEV listing or cited evidence of active exploitation. The CVSS vector indicates exploitation requires an authenticated low-privileged user and no user interaction. No public exploit details are included in the provided sources.
Researcher notes
Evidence is limited to CVE metadata and Turkish government advisory references. The CVE record identifies the weakness and affected version boundary but does not provide detailed attack paths, indicators of compromise, or exploit availability. Avoid assuming broader Mia Technology products are affected.
Mitigation direction
- Inventory MİA-MED deployments and identify installed versions.
- Upgrade MİA-MED to version 1.0.7 or later where applicable.
- Review vendor and Turkish government advisories for current remediation guidance.
- Restrict access to MİA-MED to trusted networks and users.
- Monitor application logs for unauthorized record access patterns.
Validation and detection
- Confirm whether MİA-MED is present in the environment.
- Verify each instance is version 1.0.7 or later.
- Review role-based access controls for least privilege.
- Check logs for cross-user access anomalies.
- Document compensating controls for any unpatched instance.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-639: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupPrivilege behavior lookup
The CVE wording references privilege impact, so privilege escalation and authorization behavior review may help. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.
Open ATT&CK lookupCVE-2023-6515 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 8.8 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H2.85.9TR-CERTVulnerability scoring details
Base CVSS 3.1 score
8.8HighVector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://www.usom.gov.tr/bildirim/tr-24-0087CVE reference, TR-CERT · government-resource, broken-link
- https://siberguvenlik.gov.tr/guvenlik-bildirimleri/detay/tr-24-0087CVE reference, TR-CERT · government-resource
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Authorization Bypass Through User-Controlled Key
Authorization Bypass Through User-Controlled Key represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.